✦ LIBER ✦

7157 Subgroup analysis of French patients from RECORD-1: a randomized, placebo-controlled, phase III study of everolimus, a novel therapy for patients with metastatic renal cell carcinoma

✍ Scribed by Ravaud, A.; Kay, A.; Lewohl, D.

Book ID: 122374703
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 66 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71490-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

7136 Randomized, placebo-controlled, pha

7136 Randomized, placebo-controlled, phase 3 study of everolimus, a novel therapy for patients with metastatic renal cell carcinoma: subgroup analysis of patients progressing on prior bevacizumab therapy

✍ Hutson, T.; Negrier, S.; Kay, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

719 EVEROLIMUS IN PATIENTS WITH METASTAT

719 EVEROLIMUS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: SUBGROUP ANALYSIS OF PATIENTS WITH A REDUCTION IN TUMOR BURDEN ENROLLED IN A RANDOMIZED, PLACEBO-CONTROLLED, PHASE II TRIAL

✍ S. Oudard; B. Escudier; T. Hutson; C. Porta; S. Bracarda; V. Grunwald; J. Thomps 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 194 KB

7127 Results from additional analyses of

7127 Results from additional analyses of patient reported outcomes in RECORD-1 – a randomized trial of everolimus with metastatic renal cell carcinoma patients

✍ Beaumont, J.; Cella, D.; Hollaender, N.; Zheng, J.; Baladi, J.F.; Hutson, T. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Everolimus in metastatic renal cell carc

Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study

✍ E. Calvo; B. Escudier; R.J. Motzer; S. Oudard; T.E. Hutson; C. Porta; S. Bracard 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Tivozanib Versus Sorafenib As Initial Ta

Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial

✍ Motzer, R. J.; Nosov, D.; Eisen, T.; Bondarenko, I.; Lesovoy, V.; Lipatov, O.; T 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 196 KB

The effect of everolimus on renal angiom

The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1

✍ Kingswood, J. C.; Jozwiak, S.; Belousova, E. D.; Frost, M. D.; Kuperman, R. A.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 499 KB